Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 May;45(5):382–384. doi: 10.1136/jcp.45.5.382

Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma.

K Cooper 1, C S Herrington 1, E S Lo 1, M F Evans 1, J O McGee 1
PMCID: PMC495296  PMID: 1317883

Abstract

AIMS: To determine which type of human papillomavirus (HPV) is associated with cervical adenocarcinoma and whether the virus was integrated or episomal in two continents. METHODS: Biopsy specimens from the UK (n = 16) and South Africa (n = 22) were analysed by non-isotopic in situ hybridisation (NISH) for HPV types 6, 11, 16, 18, 31, 33, and 35 on archival biopsy specimens using digoxigenin labelled probes. RESULTS: A total of 20 adenocarcinomas (53%) from both groups contained HPV DNA. In the UK group, seven and four cases contained HPV 18 (44%) and 16 (25%) respectively. In the South African group, nine cases contained HPV 18 (41%) while HPV DNA was not detectable in the other 13 cases. Hence HPV 18 was present in 80% of HPV positive adenocarcinomas. CONCLUSIONS: The HPV 16 or 18 genome was integrated in all viral positive cases. In two cases HPV 18 was also present in an episomal form. These data indicate that HPV integration is common to cervical adenocarcinoma in two continents by the same methodology. The lower prevalence of HPV 18 detection in the South African group may have been due to the presence of other or unsequenced HPV types.

Full text

PDF
382

Images in this article

383Image
on p.383
383Image
on p.383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes W., Delgado G., Kurman R. J., Petrilli E. S., Smith D. M., Ahmed S., Lorincz A. T., Temple G. F., Jenson A. B., Lancaster W. D. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol. 1988 Mar;29(3):267–273. doi: 10.1016/0090-8258(88)90225-9. [DOI] [PubMed] [Google Scholar]
  2. Cooper K., Herrington C. S., Graham A. K., Evans M. F., McGee J. O. In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol. 1991 May;44(5):406–409. doi: 10.1136/jcp.44.5.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cooper K., Herrington C. S., Graham A. K., Evans M. F., McGee J. O. In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo. J Clin Pathol. 1991 May;44(5):400–405. doi: 10.1136/jcp.44.5.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper K., Herrington C. S., Stickland J. E., Evans M. F., McGee J. O. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol. 1991 Dec;44(12):990–996. doi: 10.1136/jcp.44.12.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Farnsworth A., Laverty C., Stoler M. H. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol. 1989;8(4):321–330. doi: 10.1097/00004347-198912000-00003. [DOI] [PubMed] [Google Scholar]
  6. Gordon A. N., Bornstein J., Kaufman R. H., Estrada R. G., Adams E., Adler-Storthz K. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gynecol Oncol. 1989 Dec;35(3):345–348. doi: 10.1016/0090-8258(89)90076-0. [DOI] [PubMed] [Google Scholar]
  7. Griffin N. R., Dockey D., Lewis F. A., Wells M. Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol. 1991;10(1):36–43. doi: 10.1097/00004347-199101000-00004. [DOI] [PubMed] [Google Scholar]
  8. Leminen A., Paavonen J., Vesterinen E., Wahlström T., Rantala I., Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol. 1991 May;95(5):647–652. doi: 10.1093/ajcp/95.5.647. [DOI] [PubMed] [Google Scholar]
  9. Nagai N. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA]. Nihon Sanka Fujinka Gakkai Zasshi. 1990 Aug;42(8):823–833. [PubMed] [Google Scholar]
  10. Nielsen A. L. Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. A study by in situ hybridization with biotinylated DNA probes. Cancer. 1990 Jun 1;65(11):2588–2593. doi: 10.1002/1097-0142(19900601)65:11<2588::aid-cncr2820651132>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  11. Okagaki T., Tase T., Twiggs L. B., Carson L. F. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. J Reprod Med. 1989 Sep;34(9):639–644. [PubMed] [Google Scholar]
  12. Smotkin D., Berek J. S., Fu Y. S., Hacker N. F., Major F. J., Wettstein F. O. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol. 1986 Aug;68(2):241–244. [PubMed] [Google Scholar]
  13. Tase T., Okagaki T., Clark B. A., Manias D. A., Ostrow R. S., Twiggs L. B., Faras A. J. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res. 1988 Feb 15;48(4):993–998. [PubMed] [Google Scholar]
  14. Tase T., Okagaki T., Clark B. A., Twiggs L. B., Ostrow R. S., Faras A. J. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol. 1989;8(1):8–17. doi: 10.1097/00004347-198903000-00002. [DOI] [PubMed] [Google Scholar]
  15. Wilczynski S. P., Bergen S., Walker J., Liao S. Y., Pearlman L. F. Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol. 1988 Jun;19(6):697–704. doi: 10.1016/s0046-8177(88)80176-x. [DOI] [PubMed] [Google Scholar]
  16. Wilczynski S. P., Walker J., Liao S. Y., Bergen S., Berman M. Adenocarcinoma of the cervix associated with human papillomavirus. Cancer. 1988 Oct 1;62(7):1331–1336. doi: 10.1002/1097-0142(19881001)62:7<1331::aid-cncr2820620715>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  17. Williamson A. L., Dehaeck C. M., Soeters R. Typing of human papillomaviruses in cervical intraepithelial neoplasia grade 3 biopsies from Cape Town. J Med Virol. 1989 Jul;28(3):146–149. doi: 10.1002/jmv.1890280307. [DOI] [PubMed] [Google Scholar]
  18. Yee C., Krishnan-Hewlett I., Baker C. C., Schlegel R., Howley P. M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol. 1985 Jun;119(3):361–366. [PMC free article] [PubMed] [Google Scholar]
  19. Young F. I., Ward L. M., Brown L. J. Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridisation. J Clin Pathol. 1991 Apr;44(4):340–341. doi: 10.1136/jcp.44.4.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. de Villiers E. M. Heterogeneity of the human papillomavirus group. J Virol. 1989 Nov;63(11):4898–4903. doi: 10.1128/jvi.63.11.4898-4903.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES